Atea Pharmaceuticals, Inc.
AVIR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001593899
No open-market purchases or sales by Atea Pharmaceuticals, Inc. insiders were filed in the last 90 days; 124 institutions reported holding it in 13F filings for Q2 2026, worth $276.4M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Atea Pharmaceuticals, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 131
- 0 vs. Q4 2022
- Shares held
- 56.8M
- −1.04M (−1.8%) vs. Q4 2022
- Total value
- $190.2M
- −$87.9M (−31.6%) vs. Q4 2022
- New holders
- 16
- 43 more added
- Sold out
- 16
- 49 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AVIR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 124 | $276.4M |
| Q1 2026 | 127 | $322.8M |
| Q4 2025 | 111 | $203.5M |
| Q3 2025 | 115 | $154.2M |
| Q2 2025 | 107 | $189.7M |
| Q1 2025 | 104 | $158.3M |
| Q4 2024 | 107 | $188.7M |
| Q3 2024 | 108 | $194.0M |
| Q2 2024 | 105 | $187.7M |
| Q1 2024 | 113 | $219.6M |
| Q4 2023 | 108 | $168.3M |
| Q3 2023 | 119 | $170.6M |
| Q2 2023 | 133 | $213.3M |
| Q1 2023 | 131 | $190.2M |
| Q4 2022 | 131 | $278.1M |
| Q3 2022 | 126 | $326.8M |
| Q2 2022 | 128 | $408.7M |
| Q1 2022 | 127 | $396.6M |
| Q4 2021 | 143 | $479.2M |
| Q3 2021 | 142 | $1.99B |
| Q2 2021 | 104 | $1.27B |
| Q1 2021 | 82 | $3.20B |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Atea Pharmaceuticals, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| RBF Capital, LLC | 214,929 | $718.8K | 0.05% | −53,262−19.9% | Reduced |
| Invesco Ltd. | 216,774 | $726.2K | 0.00% | +68,845+46.5% | Added |
| Prudential Financial Inc | 239,405 | $802.0K | 0.00% | −36,300−13.2% | Reduced |
| Goldman Sachs Group Inc | 280,060 | $938.2K | 0.00% | +36,843+15.1% | Added |
| Wellington Management Group LLP | 286,233 | $958.9K | 0.00% | −11,507−3.9% | Reduced |
| Bank of New York Mellon Corp | 309,559 | $1.04M | 0.00% | −10,987−3.4% | Reduced |
| CM Management, LLC | 325,000 | $1.09M | 1.29% | +50,000+18.2% | Added |
| Banque Pictet & Cie SA | 345,077 | $1.16M | 0.01% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 379,912 | $1.27M | 0.03% | −8,000−2.1% | Reduced |
| Sectoral Asset Management Inc | 380,850 | $1.28M | 0.25% | +99,447+35.3% | Added |
| Vontobel Holding Ltd. | 380,850 | $1.28M | 0.01% | +99,447+35.3% | Added |
| Nuveen Asset Management, LLC | 385,422 | $1.29M | 0.00% | +72,018+23.0% | Added |
| Morgan Stanley | 477,185 | $1.60M | 0.00% | +37,951+8.6% | Added |
| Charles Schwab Investment Management Inc | 526,349 | $1.76M | 0.00% | −38,145−6.8% | Reduced |
| Jacobs Levy Equity Management, Inc | 632,230 | $2.12M | 0.01% | +133,172+26.7% | Added |
| Stonepine Capital Management, LLC | 684,508 | $2.29M | 0.77% | +684,508 | New |
| Northern Trust Corp | 705,044 | $2.36M | 0.00% | −5,894−0.8% | Reduced |
| Renaissance Technologies LLC | 727,700 | $2.44M | 0.00% | +107,100+17.3% | Added |
| Tang Capital Management LLC | 1,002,582 | $3.36M | 0.50% | +1,002,582 | New |
| Acadian Asset Management LLC | 1,110,715 | $3.72M | 0.02% | +242,465+27.9% | Added |
| Tyrus Capital S.A.M. | 1,260,000 | $4.22M | 24.86% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 1,490,064 | $4.99M | 0.00% | +52,705+3.7% | Added |
| Cormorant Asset Management, LP | 1,547,181 | $5.18M | 0.34% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,581,708 | $5.30M | 0.01% | +975,523+160.9% | Added |
| State Street Corp | 1,863,337 | $6.24M | 0.00% | −74,393−3.8% | Reduced |
| Federated Hermes, Inc. | 2,039,056 | $6.83M | 0.02% | −1,041,841−33.8% | Reduced |
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $8.33M | 1.04% | 00.0% | Unchanged |
| Vanguard Group Inc | 4,587,181 | $15.4M | 0.00% | −1,502,341−24.7% | Reduced |
| EcoR1 Capital, LLC | 6,184,861 | $20.7M | 0.67% | 00.0% | Unchanged |
| BlackRock Inc. | 8,041,736 | $26.9M | 0.00% | +8,164+0.1% | Added |
| FMR LLC | 11,573,379 | $38.8M | 0.00% | −164,030−1.4% | Reduced |
| Ally Bridge Group (NY) LLC | 0 | $0 | 0.00% | −962,694−100.0% | Sold out |
| Jupiter Asset Management Ltd | 0 | $0 | 0.00% | −263,056−100.0% | Sold out |
| Los Angeles Capital Management LLC | 0 | $0 | 0.00% | −175,048−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −60,400−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −57,777−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −44,346−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −28,595−100.0% | Sold out |
| Envestnet Asset Management Inc | 0 | $0 | 0.00% | −20,173−100.0% | Sold out |
| Alpine Global Management, LLC | 0 | $0 | 0.00% | −10,858−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −7,700−100.0% | Sold out |
| Bank Julius Baer & Co. Ltd, Zurich | 0 | $0 | 0.00% | −2,800−100.0% | Sold out |
| Point72 Middle East FZE | 0 | $0 | 0.00% | −2,287−100.0% | Sold out |
| Zullo Investment Group, Inc. | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −264−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −120−100.0% | Sold out |
| Romano Brothers and Company | 0 | $0 | 0.00% | −48−100.0% | Sold out |